These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 10670249)

  • 1. [Treatment with prostanoid drugs. Analysis of 131 cases].
    Castagno PL; Di Molfetta L; Merlo M; Barile G; Gaia S; Buzzacchino A; Ponzio F
    Minerva Cardioangiol; 1999 Dec; 47(12):658-9. PubMed ID: 10670249
    [No Abstract]   [Full Text] [Related]  

  • 2. Prospects of prostanoid therapy. Preliminary results.
    Castagno PL; Di Molfetta L; Merlo M; Barile G; Violato F; Buzzacchino A; Ponzio F
    Minerva Cardioangiol; 2000; 48(1-2):9-18. PubMed ID: 10829583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Microcirculation in peripheral arterial occlusive diseases will improve. Prostaglandin can prevent surgery].
    MMW Fortschr Med; 2003 Dec; 145(51-52):41. PubMed ID: 14974333
    [No Abstract]   [Full Text] [Related]  

  • 4. Short term treatment with prostanoids in critical limb ischaemia: three months follow-up.
    Martini R; Camporese G; Salmistraro G; Scomparin MA; Verlato F; Andreozzi GM
    Minerva Cardioangiol; 1999 Dec; 47(12):656-7. PubMed ID: 10670248
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of alprostadil and iloprost in digital necrosis due to secondary Raynaud's phenomenon.
    Lamprecht P; Schnabel A; Gross WL
    Br J Rheumatol; 1998 Jun; 37(6):703-4. PubMed ID: 9667634
    [No Abstract]   [Full Text] [Related]  

  • 6. The influence of iloprost on blood rheology and tissue perfusion in patients with intermittent claudication.
    Ciuffetti G; Sokola E; Lombardini R; Pasqualini L; Pirro M; Mannarino E
    Kardiol Pol; 2003 Sep; 59(9):197-204. PubMed ID: 14618196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of iloprost in patients with intermittent claudication.
    Creager MA; Pande RL; Hiatt WR
    Vasc Med; 2008 Feb; 13(1):5-13. PubMed ID: 18372433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effectiveness of prostanoids in patients with critical leg ischemia].
    Brodszky V; Farkas K; Járai Z; Landi A; Pécsvárady Z; Baji P; Balogh O; Gulácsi L; Péntek M
    Orv Hetil; 2011 Dec; 152(51):2047-55. PubMed ID: 22130202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cocaine-related peripheral vascular occlusive disease treated with iloprost in addition to anticoagulants and antibiotics.
    Mazzone A; Giani L; Faggioli P; Pichini S; Pacifici R
    Clin Toxicol (Phila); 2007; 45(1):65-6. PubMed ID: 17357385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between intravenous iloprost and vasoactive drugs in limb ischemia IIB severe. A retrospective analysis.
    Di Salvo MM; Ardita G; Giani L; Mugno F; Stevenazzi F; Mazzone A
    Minerva Cardioangiol; 2006 Jun; 54(3):377-81. PubMed ID: 16733512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Modern aspects of diagnostics and treatment for thromboangiitis obliterans].
    Abyshov NS; Zakirdzhaev EA; Aliev ZM
    Khirurgiia (Mosk); 2009; (2):75-9. PubMed ID: 19368048
    [No Abstract]   [Full Text] [Related]  

  • 12. Iloprost for chronic thromboembolic pulmonary hypertension.
    Roig Figueroa V; Herrero Pérez A; de la Torre Ferrera N; Hernández García E; Aller Alvarez JL; Para Cabello J
    Arch Bronconeumol; 2004 Jul; 40(7):326-8. PubMed ID: 15225519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vasoactive agents and prostanoids in the therapy of PAD: facts, questions, disproven assumptions].
    Heidrich H
    Hamostaseologie; 2006 Aug; 26(3):220-3. PubMed ID: 16906239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous prostaglandin E1 reduces monocyte chemoattractant protein-1 levels in peripheral arterial obstructive disease.
    Matsui K; Ikeda U; Murakami Y; Yoshioka T; Shimada K
    Am Heart J; 2003 Feb; 145(2):330-3. PubMed ID: 12595852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of iloprost for the treatment of ischaemic digits in paediatric connective tissue diseases.
    Zulian F; Corona F; Gerloni V; Falcini F; Buoncompagni A; Scarazatti M; Martini G; Zacchello F
    Rheumatology (Oxford); 2004 Feb; 43(2):229-33. PubMed ID: 12923288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical images: iloprost-induced vascular remodeling.
    Pyrpasopoulou A; Aslanidis S
    Arthritis Rheum; 2007 Jul; 56(7):2243. PubMed ID: 17599734
    [No Abstract]   [Full Text] [Related]  

  • 17. [Medical treatment of peripheral arteriopathies with alprostadil-alpha-cyclodextrin. Comparative analysis at national level of the expense/reimbursement ratio].
    Mondani P; Agus GB
    Minerva Cardioangiol; 1999 Dec; 47(12):660-1. PubMed ID: 10670250
    [No Abstract]   [Full Text] [Related]  

  • 18. A meta-analysis of randomized placebo control trials in Fontaine stages III and IV peripheral occlusive arterial disease.
    Loosemore TM; Chalmers TC; Dormandy JA
    Int Angiol; 1994 Jun; 13(2):133-42. PubMed ID: 7525794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two randomised and placebo-controlled studies of an oral prostacyclin analogue (Iloprost) in severe leg ischaemia. The Oral Iloprost in severe Leg Ischaemia Study Group.
    Eur J Vasc Endovasc Surg; 2000 Oct; 20(4):358-62. PubMed ID: 11038148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microcirculation and tolerability following i.v. infusion of PGE1 and iloprost: a randomized cross-over study in patients with critical limb ischemia.
    Schellong S; Altmann E; von Bilderling P; Rudofsky G; Waldhausen P; Rogatti W
    Prostaglandins Leukot Essent Fatty Acids; 2004 Jun; 70(6):503-9. PubMed ID: 15120713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.